Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Thiamine for the Treatment of Depression In Youth
NCT07793071Phase 2Not yet recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2026
- Primary completion
- Jan 2029
01
Overview
A Phase 2 trial of thiamine in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
thiamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07793071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07793071.